Susquehanna International Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Susquehanna International Group’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,647	Closed	-$272K	–	14628
2022 Q3	$272K	Sell	13,647 -82,645	-86%	-$1.09M	﹤0.01%	10050
2022 Q2	$663K	Buy	96,292 +34,835	+57%	+$244K	﹤0.01%	7581
2022 Q1	$572K	Buy	61,457 +8,163	+15%	+$86.9K	﹤0.01%	8637
2021 Q4	$758K	Buy	53,294 +22,779	+75%	+$394K	﹤0.01%	8028
2021 Q3	$708K	Sell	30,515 -5,538	-15%	-$131K	﹤0.01%	8473
2021 Q2	$897K	Sell	36,053 -21,189	-37%	-$569K	﹤0.01%	8064
2021 Q1	$1.6M	Buy	57,242 +49,608	+650%	+$1.79M	﹤0.01%	6463
2020 Q4	$266K	Buy	+7,634	New	+$332K	﹤0.01%	9527

Susquehanna International Group's FMTX Position: Q4 2022 in Review

Susquehanna International Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 13,647 shares — an estimated $272K sold.

Susquehanna International Group first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $1.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Susquehanna International Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Susquehanna International Group sold 13,647 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $272K.
Susquehanna International Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Susquehanna International Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.6M in Q1 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.